Dolutegravir recommended for all in new World Health Organization guidelines
Dolutegravir safety in pregnancy: risk is lower than first reported
Starting ART at a high CD4 cell count has clear benefits for people with a low viral load
One in five Americans living with HIV experience severe anxiety on an almost daily basis
Immediate treatment is probably especially beneficial for people with recent HIV infection
Cases of hair loss among African-American women reported after switch to new tenofovir formula
Antiretrovirals do not cause neurodevelopmental harm to uninfected infants
Frequent drug-drug interactions in older people with HIV in France
